ResearcherSecond Affiliated Hospital of Soochow UniversityActive in the last 2 years

Zhenyu Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7174-0733; OpenAlex author ID A5100703512. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. Co-author DOI 10.1038/s41419-024-07079-6 ↗
Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. Last author DOI 10.1038/s41419-021-04205-6 ↗
Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in … Co-author DOI 10.2147/ijn.s279258 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yecheng Li · 2 shared papers, 2020–2021 · strength 0.25
- Paper Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. DOI 10.1038/s41419-021-04205-6 ↗
- Paper Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant T… DOI 10.2147/ijn.s279258 ↗
Jian-Zhuo Jiang · 1 shared paper, 2024 · strength 0.23
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
Qian-Hui Gu · 1 shared paper, 2024 · strength 0.23
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
Yuan-yuan Liu · 1 shared paper, 2024 · strength 0.23
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
Xiaoren Zhu · 1 shared paper, 2024 · strength 0.23
- Paper Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer. DOI 10.1038/s41419-024-07079-6 ↗
Shang Cai · 1 shared paper, 2021 · strength 0.13
- Paper Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. DOI 10.1038/s41419-021-04205-6 ↗
Wei Chen · 1 shared paper, 2021 · strength 0.13
- Paper Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. DOI 10.1038/s41419-021-04205-6 ↗
Yihui Sun · 1 shared paper, 2021 · strength 0.13
- Paper Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. DOI 10.1038/s41419-021-04205-6 ↗
Wei Li · 1 shared paper, 2020 · strength 0.12
- Paper Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant T… DOI 10.2147/ijn.s279258 ↗
Wei Chen · 1 shared paper, 2020 · strength 0.12
- Paper Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant T… DOI 10.2147/ijn.s279258 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.